Drug lookup
Drug reference

entrectinib

TRK inhibitor, kinase inhibitor · antineoplastic, targeted therapy

TRK inhibitor, kinase inhibitorantineoplastic, targeted therapy
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
D
FDA category + note
Top interactionssee all 12
  • AmiodaroneSevereDatabaseDDInter
  • AmisulprideSevereDatabaseDDInter
  • AmprenavirSevereDatabaseDDInter
  • AnagrelideSevereDatabaseDDInter

Mechanism

Specific small-molecule inhibitor of NTRK fusion genes.

Indications

systemic therapy of follicular cell-derived thyroid cancers with NTRK fusion gene driver mutationsany cancers with TRK gene fusions without resistance mutationmetastatic NSCLC positive for ROS1

Pharmacokinetics

Half-life
approximately 20 h
Metabolism
CYP3A

Side effects

Serious
  • increased risk for congestive heart failure
  • cognitive impairment
  • hepatotoxicity
  • prolongation of QT intervals

Pregnancy & lactation

Pregnancy

D

Drug interactions

Amiodarone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amisulpride
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amprenavir
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Anagrelide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Apalutamide
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Aprepitant
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Arsenic Trioxide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Atazanavir
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Bedaquiline
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bepridil
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Berotralstat
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Boceprevir
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Related guidelines

Ask House about entrectinib

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team